The Brigham and Women's Hospital; Inc.;The Brigham and Womens Hospital
发明人:
Lee, Richard,Segers, Vincent
申请号：
AU2013234365
公开号：
AU2013234365B2
申请日:
2013.09.26
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2013234365B220160519.pdf#####ABSTRACT The present invention is directed stromal cell derived factor-1 peptides that have been mutated to make them resistant to digestion by the proteases dipeptidyl peptidase IV (DPPIV) and matrix metalloproteinase-2 (MMP-2) but which maintain the ability of native SDF-I to attract T cells. The mutants may be attached to membranes formed by self-assembling peptides and then implanted at sites of tissue damage to help promote repair.
